Comparison of the Financial Performance between Square Pharmaceuticals Limited and Beximco Pharmaceuticals Limited: DuPont Analysis


  • Mohammad Jafaur Ahamed BOU



Pharmaceuticals company, DuPont analysis, Operating efficiency, Bangladesh


The study attempts to make a comparison of financial strength between Square Pharmaceuticals Limited (SQPL) and Beximco Pharmaceuticals Limited (BXPL) by using the technique of DuPont analysis. Pharmaceuticals are selected here based on a purposive sampling method with the criteria of convenience in annual reports availability. The research is based on secondary data available in annual reports of FY 2018-19 of the selected companies. The study reveals that in comparison with BXPL, SQPL has been utilizing its owners’ funds more profitably, doing operational activities more efficiently, and earning enough returns for its owners. Beximco Pharmaceuticals Ltd. applies aggressive debt-equity policy, which does not magnify its earnings due to the lack of its sufficient rate of returns in comparison with interest burden, lack of core operational efficiency, and underutilization of resources. At the same time, leverage helps the SQPL to fuel the growth of the business. There is a good thing that the two companies have almost the same amount of tax burden ratio, although EBIT is highly differing between the companies. The study suggests that to achieve a high RoE, Beximco Pharmaceuticals Company must reduce its interest expenses, utilize its full capacities, and increase its assets turnover. Besides, both the pharmaceuticals are suggested to focus on the inflation-adjusted financial items in its annual reports. The study has operated only on DuPont analysis. Thus further research is recommended to conduct focusing on others such as common-size analysis, comparative analysis, trend analysis, and ratio analysis, etc. to investigate the financial health of pharmaceutical companies.



Metrics Loading ...


Download data is not yet available.

Author Biography

  • Mohammad Jafaur Ahamed, BOU

    Associate Professor (Accounting), Open School, Bangladesh Open University, Gazipur, BANGLADESH


Barry, P. J., Ellinger, P. N., Hopkin, J. A. & Baker, C. B. (2000). Financial Management in Agriculture, 6th ed. Danville, IL: Interstate Publishers, 2000, 678 pp. DOI DOI:

Bodie, Z., Kane, A., & Marcus, A. J. (2004). Essentials of Investments, 5th ed. McGraw-Hill Irwin. pp. 458–459. ISBN 0-07-251077-3

IMS (2018). Intercontinental Medical Statistics,

Liesz, J. T. (2002). Really Modified Du Pont Analysis: Five Ways to Improve Return on Equity. Unpublished research work. Available at:

McGowan, C. B., & Stambaugh, A. R. (2012). Using disaggregated return on assets to conduct a financial analysis of a commercial bank using an extension of the DuPont system of financial analysis. Accounting and Finance Research, 1(1), 152-161 DOI:

Mishelle, D. (2016). Using DuPont analysis to assess the financial performance of the top three JSE listed companies in the food industry. Investment Management and Financial Innovations, 13(2), 29-41. DOI:

Rogova, E. (2014). DuPont analysis of the efficiency and investment appeal of Russian oil-extracting companies: 8th International Scientific Conference. Business and Management, Vilnius, Lithuania. Available at

Sheela, C. S., & Karthikeyan, K. (2012). Financial performance of the pharmaceutical industry in India using DuPont analysis. European Journal of Business and Management, 4 (14). Available at:

Soliman, M. T. (2008). The use of DuPont analysis by market participants. The Accounting Review, 83(3), 823-853. DOI:

Tushar, S. (2017). Return on equity analysis using the DuPont model. International Journal of Advanced Research 5(8), pp. 1504-1508

Yang, S. P., & Yoon, D. S. (2005). The impacts of financial characteristics on profitability performances in foodservice companies. Journal of Food Service Management, 8(1), 273-293.





How to Cite

Ahamed, M. J. . (2020). Comparison of the Financial Performance between Square Pharmaceuticals Limited and Beximco Pharmaceuticals Limited: DuPont Analysis. Global Disclosure of Economics and Business, 9(1), 39-48.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>